Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
American Journal of Hematology|October 23, 2024
Toxicities and outcome after CD19-directed chimeric antigen receptor T-cell therapy for secondary neurolymphomatosisLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.Journal of Hematology & Oncology|January 14, 2026
Patterns, risk factors and management of CD19-directed chimeric antigen receptor T-cell therapy failure in CNS lymphomaLeon D Kaulen, Philipp Karschnia, Sofia Doubrovinskaia, et al.Blood|July 15, 2025
Clinical presentation, management, and outcome of TIAN in CNS lymphoma treated with CD19-CAR T-cell TherapyLeon D Kaulen, Maria Martinez-Lage, Jeremy S Abramson, et al.Neurology|March 17, 2026
Clinical Manifestations of Primary CNS T-Cell Lymphoma: A Retrospective Study of Histopathologic, Molecular, and Neuroimaging FeaturesKatharina Johanna Müller, Philipp Karschnia, Leon D Kaulen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2024
Cerebrospinal Fluid cfDNA Sequencing for Classification of Central Nervous System GliomaFlorian Iser, Felix Hinz, Dirk C Hoffmann, et al.Nature Communications|February 15, 2017
Integrated genomic analyses of de novo pathways underlying atypical meningiomasAkdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, et al.Nature Communications|April 21, 2018
Integrated genomic analyses of de novo pathways underlying atypical meningiomasAkdes Serin Harmancı, Mark W Youngblood, Victoria E Clark, et al.Nature Communications|February 6, 2024
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1Ling Hai, Dirk C Hoffmann, Robin J Wagener, et al.Proceedings of the National Academy of Sciences of the United States of America|April 12, 2023
Pleiotropic role of TRAF7 in skull-base meningiomas and congenital heart diseaseKetu Mishra-Gorur, Tanyeri Barak, Leon D Kaulen, et al.Nature Genetics|December 1, 2015
Integrated genomic characterization of IDH1-mutant glioma malignant progressionHanwen Bai, Akdes Serin Harmancı, E Zeynep Erson-Omay, et al.Pageof 9